跳至主要内容
临床试验/NCT00307905
NCT00307905撤回3 期

A Randomised, Double - Blind, Placebo Controlled Clinical Trial to Assess the Efficacy of the Homeopathic Medication TRAUMEEL S in Controlling Post-operative Pain After Fracture of Neck of Femur

Shaare Zedek Medical Center1 个研究点 分布在 1 个国家目标入组 224 人开始时间: 2011年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
撤回
入组人数
224
试验地点
1
主要终点
Cumulative 48-hour postoperative morphine consumption

研究概览

简要总结

We hypothesize that Traumeel S is more effective than placebo in reducing 48-hour mean cumulative morphine consumption in patients scheduled for surgical correction of fracture of neck of hip.

224 patients, meeting all inclusion and none of exclusion criteria, will be enrolled in the trial. Patients will be randomized to receive either intraoperative injection and post operative oral Traumeel S Tablets or placebo injection (normal saline) and indistinguishable oral placebo tablets. Baseline measurements of relevant outcome measures will taken preoperatively. Immediately after surgery, patients will receive an initial dose of morphine of 0.1mg/kg body weight. Patients will take the oral study medication for 21 days. Every four hours after surgery, patients will be asked to grade their pain on an NRS. Subsequent doses of morphine will be calculated based upon the patient's weight and current NRS, according to a preplanned scheme. Patients will be permitted to request additional morphine, beyond their calculated dose.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of either sex undergoing surgical correction of unilateral fracture of neck of hip.
  • Age over 18 years.
  • Signature upon informed consent form

排除标准

  • Participation in another clinical trial within 4 weeks prior to enrollment.
  • Refused to give verbal consent to the telephone interviews
  • Impossibility to be reached during the 14-17 days post operative
  • Inability to comply with the study protocol for any other reason
  • Previous major surgical procedure on ipsilateral hip.
  • Current use of analgesics for any other reason.
  • A history of chronic pain syndrome.
  • Abused legal or illicit drug use.
  • Hypersensitivity to botanicals of the Compositae family
  • Known sensitivity to paracetamol, codeine or tramadol.

研究组 & 干预措施

A

Active Comparator

TRAUMEEL S

干预措施: Traumeel S (Drug)

B

Placebo Comparator

placebo remedy

干预措施: Placebo remedy (Drug)

结局指标

主要结局

Cumulative 48-hour postoperative morphine consumption

时间窗: 48h

次要结局

  • Secondary: AUC of NRS scores for first 48 hrs.;(48h)
  • AUC of NRS scores for days 14-17.;(17d)
  • Composite measure of pain intensity and opiate consumption;(17d)
  • Number of primary oral analgesic tablets ingested between days 14-17;(17d)
  • ESR and hs-CPR at three and six days and six weeks;(42d)
  • IL-6 at three and six days;(6d)
  • Post operative blood loss;(48h)
  • WOMAC;(17d)
  • Safety of post operative treatment(17d)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验